Astrazeneca

Good News For India As Oxford Covid-19 Vaccine Likely To Become First To Get Nod For Emergency Use

'Moderna Vaccine 100 Per Cent Effective In Severe Cases', Company To Apply For Emergency Authorization Soon

Narendra Modi Pune Visit HIGHLIGHTS: After PM's Visit, SII CEO Says In Process Of Getting Emergency License For Vaccine

PM Modi's 3-City Tour Tomorrow: Will Review Vaccine Development At Zydus, Bharat Biotech & Serum Institute

Why AstraZeneca, Oxford 'Covishield' Vaccine A Better Fit Over Pfizer And Moderna Shots In India

India May Get 100 Million Doses of Oxford’s Coronavirus Vaccine 'Covishield' By December

Covid-19 Vaccine 'Covishield' To Be Ready By Jan 2021, Says Serum Institute CEO Adar Poonawalla

AstraZeneca Covid-19 Vaccine Trial Volunteer Dies In Brazil, Testing To Continue

Serum Institute of India Gets DCGI Approval To Resume Oxford-AstraZeneca Covid-19 Vaccine Trials

Corona Vaccine: AstraZeneca Resumes Trials In UK, What We Know Of That One Case Which Paused Trials Globally

UK Based Pharma Giant Astrazeneca Begins Clinical Trials Of New Antibody Treatment For Covid-19

Oxford Covid Vaccine Brings New Hope; Trials To Start In India Soon, Serum Institute Seeks DCGI Nod